I2O THERAPEUTICS
i2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, it leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally. i2o is focused on creating the next generation of oral peptide and protein-based therapies. The company was founded in 2019 and based in Saratoga, California.
I2O THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Allston, Massachusetts, United States
Country:
United States
Website Url:
http://www.i2obio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
7.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Nginx Euro Google Apps For Business
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sanofi Ventures
Sanofi Ventures investment in Seed Round - i2o Therapeutics
Touchdown Ventures
Touchdown Ventures investment in Seed Round - i2o Therapeutics
JDRF T1D Fund
JDRF T1D Fund investment in Seed Round - i2o Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-12 | i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman |
Official Site Inspections
http://www.i2obio.com
- Host name: 143.7.209.35.bc.googleusercontent.com
- IP address: 35.209.7.143
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "i2o Therapeutics"
i2o Therapeutics โ Next Generation Biologics & Peptides
An Unprecedented Opportunity โ4Dโ GLP-1 Combinations For Cardio-Renal-Metabolic Diseases D e-Risked. D ata Rich. D ifferentiated. D ocumented FTO & IP. Pipeline Assets Include: 2 Long-Acting GLP-1r agonists, 2 Long-Acting โฆSee details»
i2o Therapeutics - Crunchbase Company Profile
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative โฆSee details»
i2o Therapeutics - Overview, News & Similar companies - ZoomInfo
I2o Therapeutics contact info: Phone number: (408) 476-1904 Website: www.i2obio.com What does i2o Therapeutics do? i2O Therapeutics is a biotechnology company developing safe and โฆSee details»
i2o Therapeutics - LinkedIn
I2o Therapeutics Biotechnology Research Cambridge, Massachusetts 1,752 followers Boston-based biotech startup developing novel biologic therapiesSee details»
i2o Therapeutics: Contact Details and Business Profile
I2obio.com; 1 518210XXXX; View Similar People. Related Companies Sigilon Therapeutics, Inc. 64 $11.4m FogPharma. 153 $5.5m Arbor Biotechnologies. 157 Obsidian Therapeutics. 104 โฆSee details»
i2O Therapeutics - PitchBook
I2O Therapeutics General Information Description. Developer of disruptive ionic liquid technology designed to treat metabolic and inflammatory diseases. The company's biologics leverage the โฆSee details»
I2o Therapeutics, Inc. Company Profile - Dun & Bradstreet
I2o Therapeutics, Inc. Company Profile | Cambridge, MA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
i2o Therapeutics - VentureRadar
"i2o Therapeutics is a biotech company developing safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, this โฆSee details»
i2o Therapeutics - Company Profile - Tracxn
Dec 9, 2024 Email ID: *****@i2obio.com; Key Metrics. Total Funding. $53.5M in 6 rounds. Latest Funding Round. Series A, Oct 18, 2023, $3.5M. Investors. Colorcon & 6 more. Ranked. 2 nd โฆSee details»
News and Press - JDRF T1D Fund
I2O Therapeutics, a developer of novel peptide- and antibody-based oral biologic products based on a proprietary ionic liquid platform, today announced the appointment of Kurt C. Graves as โฆSee details»
i2O Therapeutics Raises $4 million in Seed Funding Co-led by โฆ
Apr 9, 2020 Visit us at www.i2OBio.com. About JDRF T1D Fund. ... The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, โฆSee details»
Org Chart i2o Therapeutics - The Official Board
For each of our 1,263,918 listed executives, discover their exact roles and their biographies.See details»
i2o Therapeutics Inc Overview - Salary.com
Discover essential details about i2o Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
i2O Therapeutics Announces the Appointment of Kurt C. Graves as ...
Oct 12, 2021 BOSTON--(BUSINESS WIRE)--i2O Therapeutics, a developer of novel peptide- and antibody-based oral biologic products based on a proprietary ionic liquid platform, today โฆSee details»
News and Press - JDRF T1D Fund
BOSTON, MA โ April 09, 2020 . BOSTONโ(Business Wire)โi2O Therapeutics, an innovative biotech company developing a platform for oral delivery of traditionally injectable biological โฆSee details»
i2O Therapeutics Announces Research Collaboration with Sanofi โฆ
Visit us at www.i2OBio.com. About Sanofi Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We โฆSee details»
i2O Therapeutics Announces Research Collaboration with Sanofi โฆ
Feb 10, 2021 Visit us at www.i2OBio.com. About Sanofi. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused โฆSee details»
JOB DESCRIPTION Title: Research Scientist Overview - i2obio.com
Interested candidates should submit a cover letter and resume to [email protected] . Created Date: 7/13/2021 2:22:42 PM ...See details»
I2o Therapeutics, Inc. (I2o Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
ไบ่งฃI2o Therapeutics, Inc. (I2o Therapeutics, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็22็ฏๆฐ้ป๏ผ็พ็ ้ขๅ:ๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผ็ฅ็ป็ณป็ป็พ็ ๏ผๆๆฏๅนณๅฐ:็็ฉ่ฏ๏ผๅๆๅค่ฝ๏ผ้ โฆSee details»
i2O Therapeutics Raises $4 million in Seed Funding Co-led by
Apr 9, 2020 Visit us at www.i2OBio.com. About JDRF T1D Fund. ... The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, โฆSee details»